This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Methods used to judge relevance and validity, and for extracting data
Not stated.
Number of primary studies included
Six studies were included.
Methods of combining primary studies
The studies were not combined.
Investigation of differences between primary studies
Not investigated.
Results of the review
From the literature, the authors reported the following:
(1) All typhoid vaccine preparations provided a similar protective efficacy of 70%.
(2) The duration of protection against hepatitis A of a single 5ml dose of human normal immunoglobulin was 6 months. A 3 dose course of the vaccine protected for a minimum of a year. Both regimens were assumed to protect 90% of those immunised against the disease.
(3)The antimalarial regimens were attributed a protective efficacy of 72% for chloroquine and proguanil and 92% for mefloquine. The number of deaths prevented by prophylaxis against typhoid, hepatitis A and malaria were 0.55, 0.29 and 9.57 respectively.
Measure of benefits used in the economic analysis
Number of cases of illness prevented.
Direct costs
Costs and quantities were reported separately.
Costs considered were the costs to the health sector and to the travellers: costs of treating patients, cost of inpatient stay, laboratory costs, costs of the vaccine and its administration, consultation and prescription charges of the GP, costs of travel to GP surgery and hospital.
Costs were derived from hospital records, 1991 government data and other published data.
Prices used were unit costs recorded in the British National Formularies (1991 and 1993) for existing and new vaccines and drugs. Costs were discounted at the rate of 6% to calculate the present value of prophylaxis at future administration. 1991 prices were used.
Indirect Costs
Costs and quantities were reported separately. Costs to the individual and the community were considered. Costs to the individual were based on estimated time off work, costed according to wages. Costs to society were the lost productivity due to illness and death. Costs were mainly derived from 1991 government data. 1991 prices were used.
